Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

Biocon Price Movement Clarification

Biocon Ltd clarified to exchanges that Ms. Kiran Mazumdar-Shaw remains Executive Chairperson and is not stepping down. The company denied reports of impending management or succession changes following media speculation and stock price movement on May 06, 2026. Management reiterated that all material information is disclosed per SEBI regulations.

Source

BSE filing, NSE: BIOCON. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Biocon Ltd: key numbers

Share price
₹351.80
Market cap
₹57,333 Cr
Revenue (annual)
₹16,927 Cr
Net profit (annual)
₹385.6 Cr
P/E (TTM)
115.8×Sector 45.9×
Promoter holding
44.68%+0.00% QoQ
FII holding
8.64%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Biocon Ltd

All →
08:25 IST BSE
Partnership

Biocon Partnership

Biocon entered a global patent settlement and license agreement with Genentech, securing early launch dates for its biosimilar Pebrilzo® (bPertuzumab) across key global markets.

From
Genentech

Other price movement clarification announcements

All →